AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

GRISEOFULVIN USP

11 registrations across 2 African markets— 11 active

Markets with GRISEOFULVIN USP

Recent registrations

Brand / ProductMarketHolderStatusExpires
O-FULVIN 500MG TABLETS (Each uncoated tablet contains Griseofulvin USP 500mg)🇬🇭GhanaactiveAug 2030
O-FULVIN 500MG TABLETS (Each uncoated tablet contains Griseofulvin USP 500mg)🇬🇭GhanaactiveAug 2030
GRISEOFULVIN ORAL SUSPENSION (Each 5ml contains Griseofulvin USP 125 mg )🇬🇭GhanaactiveOct 2029
GRISEOFULVIN ORAL SUSPENSION (Each 5ml contains Griseofulvin USP 125 mg )🇬🇭GhanaactiveOct 2029
BIOFULVIN
TABLETS
🇷🇼RwandaBIODEAL LABORATORIES LTDactiveAug 2029
LETAVIN🇬🇭GhanaLETAP PHRAMCEUTICALS LIMITED P.O BOX GP 3346activeApr 2029
LETAVIN🇬🇭GhanaLETAP PHRAMCEUTICALS LIMITED P.O BOX GP 3346activeApr 2029
SALOFULUVIN SUSPENSION🇬🇭GhanaSALOM PHARMACY LIMITED P.O BOX 4901 KUMASI GHANAactiveSept 2028
SALOFULUVIN SUSPENSION🇬🇭GhanaSALOM PHARMACY LIMITED P.O BOX 4901 KUMASI GHANAactiveSept 2028
NOVAFULVIN SUSPENSION🇬🇭GhanaactiveDec 2027
NOVAFULVIN SUSPENSION🇬🇭GhanaactiveDec 2027

GRISEOFULVIN USP in Africa — Regulatory Overview

GRISEOFULVIN USP is registered across 2 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.